We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+34.87%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$15.3B
AUM Growth
+$3.02B
(+25%)
Cap. Flow
+$216M
Cap. Flow
% of AUM
1.41%
Top 10 Holdings %
Top 10 Hldgs %
15.76%
Holding
1,113
New
368
Increased
189
Reduced
211
Closed
335
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$284M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$232M |
| 3 |
Alibaba
BABA
|
+$183M |
| 4 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$123M |
| 5 |
Oracle
ORCL
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$287M |
| 2 |
JD.com
JD
|
+$168M |
| 3 |
Take-Two Interactive
TTWO
|
+$117M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$116M |
| 5 |
Applied Materials
AMAT
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.51% |
| 2 | Technology | 20.2% |
| 3 | Consumer Discretionary | 14.79% |
| 4 | Financials | 9.67% |
| 5 | Industrials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Xeris Biopharma Holdings
XERS
$1.39B
| $618K | ﹤0.01% |
+232,410
| New | +$809K |
|
702
SEI Investments
SEIC
$12.4B
| $605K | ﹤0.01% |
10,997
-16,438
| -60% | -$859K |
|
703
Cleveland-Cliffs
CLF
$6.57B
| $585K | ﹤0.01% |
+106,009
| New | +$515K |
|
|
DAO
704
Youdao
DAO
$2.03B
| $581K | ﹤0.01% |
+15,500
| New | +$381K |
|
|
EVOP
705
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $564K | ﹤0.01% |
+24,700
| New | +$491K |
|
706
Transmedics
TMDX
$2.64B
| $560K | ﹤0.01% |
+31,274
| New | +$489K |
|
707
Protolabs
PRLB
$1.79B
| $549K | ﹤0.01% |
+4,878
| New | +$501K |
|
|
HUD
708
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $541K | ﹤0.01% |
111,035
+84,154
| +313% | +$439K |
|
|
VSTO
709
DELISTED
Vista Outdoor Inc.
VSTO
| $519K | ﹤0.01% |
+35,900
| New | +$360K |
|
710
Henry Schein
HSIC
$9.77B
| $505K | ﹤0.01% |
+8,653
| New | +$484K |
|
711
Aaon
AAON
$7.3B
| $502K | ﹤0.01% |
13,872
+10,272
| +285% | +$345K |
|
712
Graphic Packaging
GPK
$3.17B
| $494K | ﹤0.01% |
35,300
-1,083,800
| -97% | -$14.6M |
|
|
GCP
713
DELISTED
GCP Applied Technologies Inc.
GCP
| $492K | ﹤0.01% |
+26,463
| New | +$475K |
|
714
Lincoln National
LNC
$8.73B
| $486K | ﹤0.01% |
+13,200
| New | +$465K |
|
|
VLDR
715
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $473K | ﹤0.01% |
+34,000
| New | +$369K |
|
|
AAMI
716
Acadian Asset Management
AAMI
$3.08B
| $467K | ﹤0.01% |
37,500
-550,298
| -94% | -$4.5M |
|
|
RPTX
717
DELISTED
Repare Therapeutics
RPTX
| $465K | ﹤0.01% |
+15,000
| New | +$482K |
|
|
BIOR
718
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $450K | ﹤0.01% |
+200
| New | +$545K |
|
719
International Bancshares
IBOC
$4.76B
| $448K | ﹤0.01% |
14,000
+11,400
| +438% | +$328K |
|
720
State Street SPDR S&P Homebuilders ETF
XHB
$1.6B
| $439K | ﹤0.01% |
+10,000
| New | +$380K |
|
|
ETNB
721
DELISTED
89bio
ETNB
| $433K | ﹤0.01% |
+21,744
| New | +$528K |
|
722
Opko Health
OPK
$985M
| $429K | ﹤0.01% |
+125,925
| New | +$282K |
|
723
Liquidia Corp
LQDA
$7.48B
| $421K | ﹤0.01% |
+50,000
| New | +$379K |
|
724
NorthWestern Energy
NWE
$4.23B
| $420K | ﹤0.01% |
7,700
-11,000
| -59% | -$637K |
|
725
ManpowerGroup
MAN
$2.44B
| $406K | ﹤0.01% |
+5,908
| New | +$403K |
|
Similar funds
CBU
BC
Point72 Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Point72 Asset Management held 1,113 positions worth $15.3B, up 25% from $12.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Point72 Asset Management's Q2 2020 filing shows 368 new, 189 increased, 211 reduced and 335 closed positions. Its largest new stake was Merck: 3,769,218 shares worth $278M. The largest sale was Micron Technology, an estimated $287M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Point72 Asset Management's largest Q2 2020 buy was Merck: 3,769,218 shares worth $278M.
- Point72 Asset Management added most to Fiserv Inc in Q2 2020, an estimated $232M increase.
- Point72 Asset Management's biggest Q2 2020 reduction was Micron Technology, cutting an estimated $287M.
- Point72 Asset Management fully exited CSX Corp in Q2 2020, selling an estimated $110M.
- Point72 Asset Management's ten largest holdings make up 16% of its $15.3B portfolio in Q2 2020.
- Point72 Asset Management opened 368 new positions and closed 335 in Q2 2020.
- Point72 Asset Management's portfolio value rose 25% quarter-over-quarter to $15.3B.
Based on Point72 Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.